Disc Medicine (IRON) News Today $49.42 +2.27 (+4.81%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Price T Rowe Associates Inc. MD Acquires 262,690 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Price T Rowe Associates Inc. MD increased its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 23.2% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,394,637 shares of the company's stock after buying an additional 262,690 shareApril 30 at 5:10 AM | marketbeat.comWells Fargo & Company MN Grows Position in Disc Medicine, Inc. (NASDAQ:IRON)Wells Fargo & Company MN lifted its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 60.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 20,778 shares of the company's stock after purchasApril 30 at 3:23 AM | marketbeat.comAdage Capital Partners GP L.L.C. Sells 200,000 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Adage Capital Partners GP L.L.C. lessened its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 36.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 350,000 shares of the company's stock after selling 200,000 shApril 29 at 5:38 AM | marketbeat.comRaymond James Financial Inc. Makes New Investment in Disc Medicine, Inc. (NASDAQ:IRON)Raymond James Financial Inc. acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 88,002 shares of the company's stock, valued at approximatelApril 27 at 3:53 AM | marketbeat.comBlue Owl Capital Holdings LP Has $7.62 Million Holdings in Disc Medicine, Inc. (NASDAQ:IRON)Blue Owl Capital Holdings LP decreased its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 31.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 120,260 shares of the company's sApril 26, 2025 | marketbeat.comJump Financial LLC Buys Shares of 11,507 Disc Medicine, Inc. (NASDAQ:IRON)Jump Financial LLC purchased a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 11,507 shares of the company's stock, valued at approximately $730,000. SApril 25, 2025 | marketbeat.comSilverarc Capital Management LLC Acquires 6,519 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Silverarc Capital Management LLC grew its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 6.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 110,381 shares of the company's stock after buyinApril 24, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) is Bain Capital Life Sciences Investors LLC's 4th Largest PositionBain Capital Life Sciences Investors LLC decreased its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 45.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 983,500 shares of the company's stock after selliApril 23, 2025 | marketbeat.comWalleye Capital LLC Sells 182,232 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Walleye Capital LLC lowered its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 87.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,004 shares of the company's stock after sApril 22, 2025 | marketbeat.comRenaissance Technologies LLC Makes New $5.48 Million Investment in Disc Medicine, Inc. (NASDAQ:IRON)Renaissance Technologies LLC purchased a new stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 86,420 shares of the company's stock, valued at approximately $5,479,000. Renaissance TechnologieApril 22, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 44,762 Shares of Disc Medicine, Inc. (NASDAQ:IRON)JPMorgan Chase & Co. raised its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 275.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 61,017 shares of the company's stock afteApril 22, 2025 | marketbeat.comFmr LLC Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON)Fmr LLC grew its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 358.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,866,248 shares of the company's stock after purchasing an aApril 16, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of "Buy" by BrokeragesDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has been assigned an average rating of "Buy" from the eleven ratings firms that are presently covering the firm, MarketBeat reports. Ten research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendatioApril 15, 2025 | marketbeat.comVanguard Group Inc. Has $67.73 Million Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON)Vanguard Group Inc. increased its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,068,246 shares of the company's stock after acquiring an aApril 13, 2025 | marketbeat.comDisc Medicine (NASDAQ:IRON) Trading Down 7.3% - What's Next?Disc Medicine (NASDAQ:IRON) Trading Down 7.3% - What's Next?April 10, 2025 | marketbeat.comADAR1 Capital Management LLC Decreases Position in Disc Medicine, Inc. (NASDAQ:IRON)ADAR1 Capital Management LLC decreased its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 81.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,196 shares of the company's stoApril 10, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Disc Medicine (IRON) and Roche Holding (OtherRHHBY)April 9, 2025 | markets.businessinsider.comDisc Medicine: Forging Ahead In HematologyApril 9, 2025 | seekingalpha.comWellington Management Group LLP Sells 444,821 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Wellington Management Group LLP trimmed its position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 24.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 1,395,405 shares of the company's stock after selling 444,821 shares during the period. WeApril 7, 2025 | marketbeat.comPictet Asset Management Holding SA Decreases Stock Position in Disc Medicine, Inc. (NASDAQ:IRON)Pictet Asset Management Holding SA cut its position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 17.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 129,482 shares of the company's stock after selliApril 4, 2025 | marketbeat.com4,875 Shares in Disc Medicine, Inc. (NASDAQ:IRON) Purchased by Virtu Financial LLCVirtu Financial LLC bought a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 4,875 shares of the company's stock, valued at apprMarch 29, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Director Sells $310,483.18 in StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) Director Mona Ashiya sold 5,738 shares of the firm's stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $54.11, for a total transaction of $310,483.18. Following the completion of the transaction, the director now owns 186,541 shares of the company's stock, valued at approximately $10,093,733.51. The trade was a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.March 27, 2025 | marketbeat.comIs Disc Medicine, Inc. (NASDAQ:IRON) the Best Small Cap Stock to Buy Before They Explode?March 27, 2025 | msn.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 5,738 Shares of StockMarch 27, 2025 | insidertrades.comRaymond James Financial Inc. Purchases New Position in Disc Medicine, Inc. (NASDAQ:IRON)Raymond James Financial Inc. acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 88,002 shares of the company's stock, valuedMarch 25, 2025 | marketbeat.comWith 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backingMarch 23, 2025 | uk.finance.yahoo.comDisc Medicine, Inc. (NASDAQ:IRON) Director Sells $540,594.00 in StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) Director Mona Ashiya sold 10,011 shares of the company's stock in a transaction on Friday, March 21st. The shares were sold at an average price of $54.00, for a total transaction of $540,594.00. Following the completion of the transaction, the director now owns 187,297 shares of the company's stock, valued at approximately $10,114,038. The trade was a 5.07 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.March 22, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 39,656 Shares of StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) Director Mona Ashiya sold 39,656 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $54.02, for a total value of $2,142,217.12. Following the completion of the sale, the director now owns 188,981 shares of the company's stock, valued at approximately $10,208,753.62. This trade represents a 17.34 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.March 22, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 10,011 Shares of StockMarch 22, 2025 | insidertrades.comVictoria’s Secret, Bitdeer, and More Stocks See Activist ActionMarch 21, 2025 | msn.comDisc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of "Buy" by AnalystsDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has earned an average rating of "Buy" from the eleven analysts that are covering the company, MarketBeat.com reports. Ten analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. TMarch 20, 2025 | marketbeat.comCantor Fitzgerald Raises Disc Medicine (NASDAQ:IRON) Price Target to $132.00Cantor Fitzgerald upped their target price on shares of Disc Medicine from $99.00 to $132.00 and gave the company an "overweight" rating in a report on Tuesday.March 19, 2025 | marketbeat.comDisc Medicine (IRON) Gets a Buy from Cantor FitzgeraldMarch 19, 2025 | markets.businessinsider.comDisc Medicine price target raised to $132 from $99 at Cantor FitzgeraldMarch 18, 2025 | msn.comDisc Medicine (NASDAQ:IRON) Shares Down 3% - Here's What HappenedDisc Medicine (NASDAQ:IRON) Trading Down 3% - Time to Sell?March 15, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Director Mona Ashiya Sells 83,182 SharesDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) Director Mona Ashiya sold 83,182 shares of the company's stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $54.45, for a total transaction of $4,529,259.90. Following the sale, the director now directly owns 194,209 shares in the company, valued at $10,574,680.05. This represents a 29.99 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.March 13, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 202,146 Shares of StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) Director Mona Ashiya sold 202,146 shares of the company's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $54.29, for a total transaction of $10,974,506.34. Following the completion of the transaction, the director now directly owns 208,742 shares of the company's stock, valued at $11,332,603.18. This represents a 49.20 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.March 13, 2025 | marketbeat.comMona Ashiya Sells 83,182 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockMarch 13, 2025 | insidertrades.comDisc Medicine, Inc. (NASDAQ:IRON) Shares Bought by Victory Capital Management Inc.Victory Capital Management Inc. raised its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 7.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 236,244 shares of the company's stock after acquiring an additionMarch 13, 2025 | marketbeat.comDisc Medicine (IRON) to Release Quarterly Earnings on ThursdayDisc Medicine (NASDAQ:IRON) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.March 13, 2025 | marketbeat.comMorgan Stanley Reaffirms Overweight Rating for Disc Medicine (NASDAQ:IRON)Morgan Stanley reissued an "overweight" rating and set a $85.00 price target on shares of Disc Medicine in a report on Friday.March 8, 2025 | marketbeat.comCantor Fitzgerald Comments on Disc Medicine FY2025 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Analysts at Cantor Fitzgerald lifted their FY2025 EPS estimates for Disc Medicine in a research note issued to investors on Wednesday, March 5th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will post earnings per share ofMarch 8, 2025 | marketbeat.comDisc Medicine assumed with an Overweight at Morgan StanleyMarch 8, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI), Disc Medicine (IRON) and PTC Therapeutics (PTCT)March 7, 2025 | markets.businessinsider.comStifel Nicolaus Sticks to Their Buy Rating for Disc Medicine (IRON)March 4, 2025 | markets.businessinsider.comDisc Medicine price target raised to $75 from $73 at ScotiabankMarch 3, 2025 | markets.businessinsider.comDisc Medicine (NASDAQ:IRON) Given New $75.00 Price Target at ScotiabankScotiabank increased their target price on shares of Disc Medicine from $73.00 to $75.00 and gave the stock a "sector outperform" rating in a report on Monday.March 3, 2025 | marketbeat.comHC Wainwright Predicts Disc Medicine FY2029 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Disc Medicine in a report issued on Friday, February 28th. HC Wainwright analyst D. Tsao anticipates that the company will post earnings of $6.36 per share for the year. HCMarch 3, 2025 | marketbeat.comLeerink Partnrs Comments on Disc Medicine Q1 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Disc Medicine in a research report issued on Thursday, February 27th. Leerink Partnrs analyst T. Smith forecasts that the company will earn ($1.01) per sMarch 3, 2025 | marketbeat.comDisc Medicine (NASDAQ:IRON) Releases Quarterly Earnings Results, Beats Estimates By $0.08 EPSDisc Medicine (NASDAQ:IRON - Get Free Report) posted its earnings results on Thursday. The company reported ($0.98) earnings per share for the quarter, beating the consensus estimate of ($1.06) by $0.08.February 28, 2025 | marketbeat.com Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address IRON Media Mentions By Week IRON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRON News Sentiment▼1.550.85▲Average Medical News Sentiment IRON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRON Articles This Week▼85▲IRON Articles Average Week Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TG Therapeutics News Telix Pharmaceuticals Limited American Depositary Shares News Blueprint Medicines News Sarepta Therapeutics News Axsome Therapeutics News Nuvalent News Verona Pharma News Grifols News Krystal Biotech News ADMA Biologics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRON) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IRON Stock Free IRON Stock Alerts